Chronic kidney disease
Conditions
Interventions
Control group:Conventional treatment
Sponsors
Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. It conforms to the western medicine diagnostic criteria for stage 1-3 chronic kidney disease, and according to the CKD staging criteria for stage 1-3 (eGFR>30 ml/min / 1.73 m2) (CkD-EPI formula: Women: Serum creatinine =90cm for male and 85cm for female;Hypertriglyceridemia, defined as serum triglyceride concentration >= 1.70mmol /L,Low high-density lipoprotein cholesterol, defined as serum high-density lipoprotein cholesterol concentration HDL-C& LT; 1.04 the tendency for L; Hypertension, defined as systolic blood pressure (SBP)>=130 mm Hg, diastolic blood pressure (DBP)>=85 mm Hg, or treated with blood pressure lowering drugs; High fasting blood glucose >=6.1mmol/L or glucose load >=7.8mmol /L 2 h after meal or diabetes history; 4. Those who voluntarily accept the drug treatment and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients who are allergic to acupuncture or wire embedding, or patients who are known to be allergic to the drugs used; 2) Patients with severe primary diseases such as heart, brain, liver and hematopoietic system; 3) Patients with acute metabolic disorders such as diabetic ketoacidosis within the past month; 4) Acute renal failure patients, associated with urinary tract infection, menstrual period, intense exercise, cold and other stress states; 5) Mentally ill patients, pregnant or lactating women; 6) Those who are participating in other drug clinical trials or have participated in other clinical trials within 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insulin resistance index; | — |
Countries
China
Contacts
Public ContactZhang Xinxian
Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed